41 – 50 of 89
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
The accuracy and robustness of plasma biomarker models for amyloid PET positivity
Benedet, Andréa L. ; Brum, Wagner S. ; Hansson, Oskar LU
; Karikari, Thomas K.
; Zimmer, Eduardo R.
; Zetterberg, Henrik
LU
; Blennow, Kaj
LU
and Ashton, Nicholas J.
(2022)
In Alzheimer's Research & Therapy
14(1).
p.26-26
- Contribution to journal › Article
-
Mark
Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease
Giannisis, Andreas ; Al-Grety, Asma ; Carlsson, Henrik ; Patra, Kalicharan ; Twohig, Daniel LU
; Sando, Sigrid Botne
; Lauridsen, Camilla
; Berge, Guro
; Grøntvedt, Gøril Rolfseng
and Bråthen, Geir
, et al.
(2022)
In Alzheimer's Research & Therapy
14(1).
- Contribution to journal › Article
- 2021
-
Mark
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Cicognola, Claudia LU
; Hansson, Oskar
LU
; Scheltens, Philip
; Kvartsberg, Hlin
; Zetterberg, Henrik
LU
; Teunissen, Charlotte E.
and Blennow, Kaj
LU
(2021)
In Alzheimer's Research and Therapy
13(1).
- Contribution to journal › Article
-
Mark
In vivo tau pathology is associated with synaptic loss and altered synaptic function
- Contribution to journal › Article
-
Mark
Biomarker testing in MCI patients—deciding who to test
van Maurik, Ingrid S. ; Rhodius-Meester, Hanneke F.M. ; Teunissen, Charlotte E. ; Scheltens, Philip ; Barkhof, Frederik ; Palmqvist, Sebastian LU
; Hansson, Oskar
LU
; van der Flier, Wiesje M.
and Berkhof, Johannes
(2021)
In Alzheimer's Research and Therapy
13(1).
- Contribution to journal › Article
-
Mark
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
Cicognola, Claudia LU
; Janelidze, Shorena
LU
; Hertze, Joakim
LU
; Zetterberg, Henrik
LU
; Blennow, Kaj
LU
; Mattsson-Carlgren, Niklas
LU
and Hansson, Oskar
LU
(2021)
In Alzheimer's Research and Therapy
13(1).
- Contribution to journal › Article
-
Mark
Tau-related grey matter network breakdown across the Alzheimer’s disease continuum
Pelkmans, Wiesje LU ; Ossenkoppele, Rik LU ; Dicks, Ellen ; Strandberg, Olof LU ; Barkhof, Frederik ; Tijms, Betty M. ; Pereira, Joana B. LU and Hansson, Oskar LU
(2021)
In Alzheimer's Research and Therapy
13(1).
- Contribution to journal › Article
-
Mark
Strategies to reduce sample sizes in Alzheimer’s disease primary and secondary prevention trials using longitudinal amyloid PET imaging
- Contribution to journal › Article
-
Mark
Pathological drivers of neurodegeneration in suspected non-Alzheimer’s disease pathophysiology
Wisse, L. E.M. LU
; de Flores, R.
; Xie, L.
; Das, S. R.
; McMillan, C. T.
; Trojanowski, J. Q.
; Grossman, M.
LU
; Lee, E. B.
; Irwin, D.
and Yushkevich, P. A.
, et al.
(2021)
In Alzheimer's Research and Therapy
13.
- Contribution to journal › Article
- 2020
-
Mark
The age-related effect on cognitive performance in cognitively healthy elderly is mainly caused by underlying AD pathology or cerebrovascular lesions : implications for cutoffs regarding cognitive impairment
Borland, Emma LU
; Stomrud, Erik
LU
; van Westen, Danielle
LU
; Hansson, Oskar
LU
and Palmqvist, Sebastian
LU
(2020)
In Alzheimer's Research & Therapy
12(1).
- Contribution to journal › Article